Supplementary Table 1 from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
crossref(2023)
摘要
PDF file - 6K, Crizotinib and ganetespib synergistically inhibit colony growth of NIH3T3 cells expressing constitutively active, TKI-resistant MET (MET-Y1248H).
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要